Skip to main content

Advertisement

SpringerLink
Log in

Associate Editor’s Commentary: Innovation Nation

  • Commentary
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kolata C. Doubt on tactic in Alzheimer’s battle. New York Times. August 18, 2010. http://www.nytimes.com/2010/08/19/health/19alzheimers.html.

  2. DiMasi JA. Hansen RW. Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003:22:151–185.

    Article  Google Scholar 

  3. Cutler D. McClellan M. Is technological change in medicine worth it? HealthAffairs. http://content.healthaffairs.org/content/20/15/11.full.

Download references

Author information

Authors and Affiliations

  1. Center for Medicine in the Public Interest, USA

    Peter J. Pitts

Authors
  1. Peter J. Pitts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter J. Pitts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pitts, P.J. Associate Editor’s Commentary: Innovation Nation. Ther Innov Regul Sci 45, 229–231 (2011). https://doi.org/10.1177/009286151104500302

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286151104500302

Search

Navigation